Pharma s Prescription

Pharma s Prescription
Author: Kamal Biswas
Publsiher: Academic Press
Total Pages: 224
Release: 2013-10-21
ISBN 10: 0124076882
ISBN 13: 9780124076884
Language: EN, FR, DE, ES & NL

Pharma s Prescription Book Review:

The pharmaceutical industry needs a shot in the arm – and not a moment too soon. The executive suite is mired in a bygone era, a time when extensive, well-funded pharmaceutical R&D produced blockbuster drugs, kept everything in-house and reaped the financial rewards. But that way of working needs to change. Executives now need to know what the technologists in their companies are doing in order to survive the next decade. Written for those new to industry, as well as for experienced professionals or specialists looking to expand their knowledge, this book is a must-read for business executives and information technologists alike. Pharma’s Prescription bridges the knowledge gap between current business practices and the most valuable technologies today. This book is filled with practical, real-life examples from industry and is a straightforward guide for all pharmaceutical and information technology executives who need to improve their businesses. Focuses on practical solutions that are easily incorporated in your day-to-day work Integrates business operations and information technology Highlights the industry's top turn-around stories Discusses pharmaceutical industry trends, growth opportunities, innovation drivers, regulatory complexities, and emerging market operations

A Prescription for Savings

A Prescription for Savings
Author: United States. Congress. Senate. Special Committee on Aging
Publsiher: Unknown
Total Pages: 137
Release: 2011
ISBN 10:
ISBN 13: UCSD:31822038353603
Language: EN, FR, DE, ES & NL

A Prescription for Savings Book Review:

Warning the Growing Danger of Prescription Drug Diversion

Warning  the Growing Danger of Prescription Drug Diversion
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Manufacturing, and Trade
Publsiher: Unknown
Total Pages: 360
Release: 2012
ISBN 10:
ISBN 13: MINN:31951D03619327E
Language: EN, FR, DE, ES & NL

Warning the Growing Danger of Prescription Drug Diversion Book Review:

Importation of Prescription Drugs

Importation of Prescription Drugs
Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Publsiher: Unknown
Total Pages: 125
Release: 2005
ISBN 10:
ISBN 13: PURD:32754077531766
Language: EN, FR, DE, ES & NL

Importation of Prescription Drugs Book Review:

Generation Rx

Generation Rx
Author: Greg Critser
Publsiher: Houghton Mifflin Harcourt
Total Pages: 308
Release: 2007
ISBN 10: 9780618773565
ISBN 13: 0618773568
Language: EN, FR, DE, ES & NL

Generation Rx Book Review:

Based on interviews with scientists and corporate executives in the nation's most powerful pharmaceutical companies, this probing look at the state of the nation's health in the midst of a pharmaceutical revolution concludes that America's love affair with drugs is radically transforming the nation, beginning with the youngest generation. Reprint.

Pharma

Pharma
Author: Gerald Posner
Publsiher: Avid Reader Press / Simon & Schuster
Total Pages: 816
Release: 2020-03-10
ISBN 10: 1501151894
ISBN 13: 9781501151897
Language: EN, FR, DE, ES & NL

Pharma Book Review:

BEST BOOKS OF MARCH - APPLE BOOKS TOP TEN PICKS FOR MARCH BOOKS - CHRISTIAN SCIENCE MONITOR BEST TRUE CRIME PICKS IN MARCH - CRIMEREADS MOST ANTICIPATED BOOKS OF 2020 - LITHUB Award-winning journalist and New York Times bestselling author Gerald Posner traces the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and uncovers how those once entrusted with improving life have often betrayed that ideal to corruption and reckless profiteering—with deadly consequences. Pharmaceutical breakthroughs such as anti­biotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on pre­scription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. Pharma introduces brilliant scientists, in-corruptible government regulators, and brave whistleblowers facing off against company exec­utives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are part of the industry’s DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids. Pharma also uncovers the real story of the Sacklers, the family that became one of America’s wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis. Relying on thousands of pages of government and corporate archives, dozens of hours of interviews with insiders, and previously classified FBI files, Posner exposes the secrets of the Sacklers’ rise to power—revelations that have long been buried under a byzantine web of interlocking companies with ever-changing names and hidden owners. The unexpected twists and turns of the Sackler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug com­panies have put earnings ahead of patients.

Prescription Games

Prescription Games
Author: Jeffrey Robinson
Publsiher: McClelland & Stewart
Total Pages: 262
Release: 2001
ISBN 10:
ISBN 13: PSU:000046191168
Language: EN, FR, DE, ES & NL

Prescription Games Book Review:

The major pharmaceutical companies, according to John le Carré – who has based his novel The Constant Gardener on their depredations – “are engaged in the systematic corruption of the medical profession, country by country.” Jeffrey Robinson can back up that charge. In Prescription Games, Jeffrey Robinson exposes the yawning abyss between the claims to altruism made by pharmaceutical companies and the harsh reality of their everyday practice. When the industry claims that the enormous markup they charge for new drugs pays the cost of developing new ones, they don’t say that as much as 80 per cent of R&D money is actually directed at developing drugs designed to compete with existing brands, or at creating variations on drugs whose patents are about to expire – expenditures only the industry itself (and its shareholders) will benefit from. Within the industry, there are “blockbuster” drugs that create vast wealth for the companies that manufacture them. Most are designed to treat conditions that are endemic among prosperous, western populations that can afford them. But there are no blockbuster drugs to treat diseases like tuberculosis, cholera, and malaria that ravage the Third World, because Third World countries can’t afford the prices. People in Africa and Asia die from new strains of tuberculosis while people in Europe and North America are offered expensive treatments for obesity, hair loss, and sexual dysfunction. In this hard-hitting exposé, Robinson also examines the extension of patent protection, the end of generic drug competition in Canada, the Nancy Olivieri scandal (how a drug manufacturer fought to conceal research findings that would damage sales of its product), the illicit drug trade, and espionage among drug manufacturers.

Voice Data

Voice   Data
Author: Anonim
Publsiher: Unknown
Total Pages: 329
Release: 2006
ISBN 10:
ISBN 13: UOM:39015081473368
Language: EN, FR, DE, ES & NL

Voice Data Book Review:

Bad Pharma

Bad Pharma
Author: Ben Goldacre
Publsiher: Signal
Total Pages: 304
Release: 2013-02-05
ISBN 10: 0771036310
ISBN 13: 9780771036316
Language: EN, FR, DE, ES & NL

Bad Pharma Book Review:

We all feel uncomfortable about the role of profit in healthcare, we all have a vague notion that the global $600bn pharmaceutical industry is somehow evil and untrustworthy, but that sense rarely goes beyond a flaky, undifferentiated new age worldview. Bad Pharma puts real flesh on those bones, revealing the rigged evidence used by drug companies. Bad information means bad treatment decisions, which means patients suffer and die: there is no climactic moment of villainy, but drugs are used which are overpriced, less effective, and have more side effects. There are five cheap, easy things we can do to fix the problem. Bad Pharma takes a big dirty secret out into the open, and will provide a single focus for concerns people have both inside and outside medicine.

Business Periodicals Index

Business Periodicals Index
Author: Anonim
Publsiher: Unknown
Total Pages: 329
Release: 2009
ISBN 10:
ISBN 13: CORNELL:31924111269415
Language: EN, FR, DE, ES & NL

Business Periodicals Index Book Review:

In Re Brand Name Prescription Drugs Antitrust Litigation

In Re Brand Name Prescription Drugs Antitrust Litigation
Author: Anonim
Publsiher: Unknown
Total Pages: 329
Release: 1997
ISBN 10:
ISBN 13: UILAW:0000000003487
Language: EN, FR, DE, ES & NL

In Re Brand Name Prescription Drugs Antitrust Litigation Book Review:

Death by Prescription

Death by Prescription
Author: Terence H. Young
Publsiher: Unknown
Total Pages: 374
Release: 2009
ISBN 10:
ISBN 13: IND:30000126268766
Language: EN, FR, DE, ES & NL

Death by Prescription Book Review:

A harrowing true account of a man's crusade against those he held responsible for his teenage daughter's death from a reaction to a prescribed medication reveals his discovery about how thousands die every year from drug complications that are considered to be acceptable in accordance with current regulations and profit-minded goals. Original.

Big Pharma

Big Pharma
Author: Jacky Law
Publsiher: Robinson
Total Pages: 266
Release: 2006
ISBN 10:
ISBN 13: NWU:35556037153509
Language: EN, FR, DE, ES & NL

Big Pharma Book Review:

Pharmaceutical medicine is very, very big business. The top ten players earned more than $200 billion in 2003. One drug, Pfizer's cholesterol pill Lipitor, had sales of more than $9 billion. This kind of money buys an awful lot of friends among doctors and politicians. Most of those involved in the formulation of public health policy seems happy with the present system. The trouble is that the public is starting to have doubts. There is a growing sense that the vast profits of drug companies and their control of the research agenda might not be that good for our health. Jacky Law takes the reader on a journey through the pharmaceutical business and shows how the public is quite right to be concerned about conventional medicine, as it has developed since the late 1970s. She tells a story of spectacular regulatory failure, phenomenally high prices, betrayal of the public interest and a growing awareness among ordinary people that things could be very different. Sophisticated marketing and public relations, not scientific excellence, have helped corporations to preside unchallenged over matters of life and death. It is time, Law argues, for us to take responsibility for our health, not as passive consumers of pharmaceutical medicine, but as informed citizens.

Genetic Engineering News

Genetic Engineering News
Author: Anonim
Publsiher: Unknown
Total Pages: 329
Release: 2006
ISBN 10:
ISBN 13: STANFORD:36105123646494
Language: EN, FR, DE, ES & NL

Genetic Engineering News Book Review:

Foundations of Business Decision Making

Foundations of Business Decision Making
Author: Anonim
Publsiher: Unknown
Total Pages: 722
Release: 2008
ISBN 10: 9780324688511
ISBN 13: 0324688512
Language: EN, FR, DE, ES & NL

Foundations of Business Decision Making Book Review:

ADHD Nation

ADHD Nation
Author: Alan Schwarz
Publsiher: Simon and Schuster
Total Pages: 352
Release: 2017-09-05
ISBN 10: 1501105922
ISBN 13: 9781501105920
Language: EN, FR, DE, ES & NL

ADHD Nation Book Review:

More than 1 in 7 American children get diagnosed with ADHD - three times what experts have said is appropriate - meaning that millions of kids are misdiagnosed and taking medications such as Adderall or Concerta for a psychiatric condition they probably do not have. The numbers rise every year. And still, many experts and drug companies deny any cause for concern. In fact, they say that adults and the rest of the world should embrace ADHD and that its medications will transform their lives.

The Insecure American

The Insecure American
Author: Hugh Gusterson,Catherine Besteman
Publsiher: Univ of California Press
Total Pages: 392
Release: 2009-11-24
ISBN 10: 0520945085
ISBN 13: 9780520945081
Language: EN, FR, DE, ES & NL

The Insecure American Book Review:

Americans are feeling insecure. They are retreating to gated communities in record numbers, fearing for their jobs and their 401(k)s, nervous about their health insurance and their debt levels, worrying about terrorist attacks and immigrants. In this innovative volume, editors Hugh Gusterson and Catherine Besteman gather essays from nineteen leading ethnographers to create a unique portrait of an anxious country and to furnish valuable insights into the nation's possible future. With an incisive foreword by Barbara Ehrenreich, the contributors draw on their deep knowledge of different facets of American life to map the impact of the new economy, the "war on terror," the "war on drugs," racial resentments, a fraying safety net, undocumented immigration, a health care system in crisis, and much more. In laying out a range of views on the forces that unsettle us, The Insecure American demonstrates the singular power of an anthropological perspective for grasping the impact of corporate profit on democratic life, charting the links between policy and vulnerability, and envisioning alternatives to life as an insecure American.

Kentucky Law Journal

Kentucky Law Journal
Author: Anonim
Publsiher: Unknown
Total Pages: 329
Release: 2005
ISBN 10:
ISBN 13: UCAL:B5230219
Language: EN, FR, DE, ES & NL

Kentucky Law Journal Book Review:

Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse
Publsiher: National Academies Press
Total Pages: 482
Release: 2017-09-28
ISBN 10: 0309459575
ISBN 13: 9780309459570
Language: EN, FR, DE, ES & NL

Pain Management and the Opioid Epidemic Book Review:

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Ask Your Doctor about Prescription Drug Advertising Patient Autonomy and the Role of the FDA

Ask Your Doctor about     Prescription Drug Advertising  Patient Autonomy  and the Role of the FDA
Author: Jennifer Grace Wilson
Publsiher: Unknown
Total Pages: 158
Release: 2006
ISBN 10:
ISBN 13: UCAL:C3504336
Language: EN, FR, DE, ES & NL

Ask Your Doctor about Prescription Drug Advertising Patient Autonomy and the Role of the FDA Book Review: